|
Due to the lack of supplemental funding from Congress, the Health Resources and Services Administration (HRSA) stopped accepting claims for reimbursement of costs associated with administering COVID-19 vaccines to uninsured patients as of April 5. Refer to the COVID-19 Vaccine Provider Weekly Update on March 30, 2022 for additional details.
As outlined in your provider enrollment agreement, participating providers must continue to administer COVID-19 vaccine at no cost to all patients to ensure equitable access for all people. CDC clarified this week that enrolled providers are prohibited from doing the following specific actions:
- Administering COVID-19 vaccine at any out-of-pocket cost to the recipient.
- Denying anyone vaccination, or differentially reducing appointment access, based on the vaccine recipient’s coverage status or network status.
- Charging an office visit or other fee if COVID-19 vaccination is the sole medical service provided.
- Requiring additional medical services to receive COVID-19 vaccination.
- Seeking any reimbursement, including through balance billing, from the vaccine recipient.
For more information please visit: CDC: Requirements for COVID-19 Vaccination Program Providers.
Starting April 11 you will have the option to opt out of all adult vaccine ancillary supply kits, including the Pfizer adult ancillary kits. If you would like to opt out, make a note in the Special Delivery Instructions field when ordering in MIIC. The opt out option is not currently available for pediatric COVID-19 vaccine as Pfizer pediatric ancillary kits contain the diluent necessary to administer the vaccine.
|
